A reproducibility review asks whether another laboratory, using the same documented materials and methods, would obtain a comparable result. For research scientists and materials managers, that question makes the evidence trail as important as the experiment. Damage in transit, an incorrect catalogue item, or a quality concern can interrupt that trail before the review begins. Research Sciences publishes a Refunds & Returns Policy that addresses these three situations, and the practical steps taken immediately after discovery often shape how quickly a case can be resolved. All materials are supplied for controlled in-vitro research only and are not for human or veterinary use; they are not medicines, medical devices, injectables, treatments or food supplements.
The published position is narrow: no returns once dispatched, because the goods are specialist and perishable. Refunds are provided only for damage, incorrect supply or quality issues. A refund request is therefore not a routine return but an evidence-based claim. Ahead of a reproducibility review, that claim must show what arrived, what was expected, what was observed and how the material was stored.
Evidence First: Preparing a Refund Case for a Reproducibility Review
The strongest case begins with the physical label. Research Sciences vial labels use a reference format that combines the SKU code and expiry date, for example BPC10-03/27. That reference links to the corresponding CoA and should be quoted in every communication about damage, incorrect supply or quality. Materials managers should record it exactly as printed rather than relying only on the order confirmation. The CoA that accompanies the specific batch should be opened and checked. The homepage lists “CoAs Janoshik Analytical Reports”, and the shop states that every product includes a CoA for purity and identity. Published purity figures are the shop’s current wording and should be reconfirmed on the live site and on the batch document.
Photographs are equally important. For damage, images should show the outer packaging, the inner packaging, the vial or container, the label and any visible breach. For incorrect supply, images should show the label, the catalogue item received and the packing slip or order record side by side. A materials manager should not discard packaging or affected vials until the supplier has responded. Keeping the original box, any desiccant and the dispatch label helps establish the condition of the consignment on arrival. These records are not only for the refund request; they become part of the reproducibility file.
The Batch Reference and CoA
If the physical label reference and the CoA do not appear to match, raise the discrepancy before any material is used in an assay. Restocked products may carry the same Internal Test Reference (ITR) as earlier stock. The published FAQ explains that an ITR links to associated sample testing reports but does not confirm that separate deliveries come from the same production lot or have had separate independent testing. Vial cap colours and other packaging details may vary; they are not indicators of identity, analytical quality or manufacturing origin. For a reproducibility review, the batch reference, CoA and order number should be captured in one place.
Communication and Order Details
The first email should include the order number, the batch reference, a short factual description of the issue and the supporting photographs. It should state whether the material has been opened or reconstituted. If reconstitution formed part of an in-vitro laboratory workflow, record the diluent volume, concentration and storage conditions rather than reconstructing them later. The shop’s free reconstitution calculator is for laboratory research use only and must not be used for human or veterinary dosing. Clear, complete communication reduces the risk of delay.
Damage and Incorrect Supply: Practical Steps for Materials Managers
Damage in transit should be documented before the consignment is unpacked further. Photograph the outer carton, inner packing, vial, label and any visible crack, leak or seal failure. Keep the packaging and do not dispose of the affected material until Research Sciences has responded. Contact the shop promptly with the order number and batch reference, because the policy provides for refunds for damage but does not accept returns once an order has been dispatched. The message should state what was found and attach the images. A brief factual account is more useful than a general complaint.
Incorrect supply covers the wrong catalogue item, the wrong quantity or a mismatch between the label and the order record. Stop before using the material in an assay. Photograph the label, the item and the packing slip together, and check the batch reference against the CoA. If the item is not the one ordered, the refund route is based on incorrect supply rather than a general return. Materials managers should keep the original packaging and any enclosed documents, because they help the supplier trace the dispatch and compare it with the order record.
Timeliness matters ahead of a reproducibility review. Waiting until the review is underway can compress the time available to resolve the claim and may leave the review file without a clear account of the discrepancy. The initial email should be concise: order number, batch reference, photographs, whether the vial is intact and whether it has been opened. All materials remain research-use-only and are not for human or veterinary use; they are not for therapeutic, clinical or diagnostic purposes. Correspondence should be stored with the batch records.
Quality Issues and the Reproducibility Review: Handling, Documentation and Escalation
An unexpected in-vitro assay result does not by itself establish a quality defect. Before raising a quality issue, review the handling record: storage of lyophilised material at −20°C or below, sealed with desiccant and protected from moisture, heat and light; avoidance of repeated freeze–thaw cycles; and short-term storage of reconstituted material at 2–8°C within the laboratory workflow. Check that the correct diluent and in-vitro concentration were used, that controls behaved as expected and that the batch reference matches the CoA. This internal check distinguishes a handling factor from a supply concern and strengthens any later refund request under the quality route.
If the concern remains after that review, assemble the evidence. The batch reference, CoA, order number, storage logs, reconstitution records and a short description of the assay context should be sent together. Compare the physical label with the CoA route described on the Peptide uk catalogue pages and the specific batch certificate. The published ITR caveat should be noted: a shared reference links to sample testing reports but does not prove that separate deliveries share a production lot or have had separate independent testing. This matters when the reproducibility review depends on lot-level traceability.
Escalation should be factual and specific. State whether the issue is visible damage, an incorrect item or quantity, or a quality concern that persists after handling checks. Refunds are provided only for damage, incorrect supply or quality issues under the published Refunds & Returns Policy. The affected material should be retained until the supplier has responded, and the correspondence should be added to the review file. All materials are for controlled in-vitro research only and are not for human or veterinary use; they are not medicines, medical devices, injectables, treatments or food supplements.
